Enhanced anandamide plasma levels in patients with complex regional pain syndrome following traumatic injury: A preliminary report

European Surgical Research

Volumn 43, Issue 4, 2009, Pages 325-329

  Kaufmann, I ^a   Hauer, D ^a   Huge, V ^a   Vogeser, M ^b   Campolongo, P ^c   Chouker, A ^a   Thiel, M ^a   Schelling, G ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anandamide; Complex regional pain syndrome; Endocannabinoid; Pain; Stress

Indexed keywords

ANANDAMIDE;

ADULT; AGE DISTRIBUTION; ARM INJURY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEG INJURY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; TANDEM MASS SPECTROMETRY;

ADULT; ARACHIDONIC ACIDS; BLOOD CHEMICAL ANALYSIS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOCANNABINOIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYUNSATURATED ALKAMIDES; PROSPECTIVE STUDIES; REFLEX SYMPATHETIC DYSTROPHY; TANDEM MASS SPECTROMETRY; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 69549133337     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235870     Document Type: Article

References (48)

1. Birklein F: Complex regional pain syndrome. J Neurol 2005; 252: 131-138.
2. Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR: Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med 2007; 8: 326-331.
3. Jänig W, Baron R: Complex regional pain syndrome: mystery explained? Lancet Neurol 2003; 2: 687-697. (Pubitemid 37311322)
4. Juottonen K, Gockel M, Silen T, Hurri H, Hari R, Forss N: Altered central sensorimotor processing in patients with complex regional pain syndrome. Pain 2002; 98: 315-323.
5. Maihöfner C, Baron R, Decol R, Binder A, Birklein F, Deuschl G, Handwerker HO, Schattschneider J: The motor system shows adaptive changes in complex regional pain syndrome. Brain 2007; 130: 2671-2687.
6. McMahon SB, Cafferty WBJ, Marchand F: Immune and glial cell factors as pain mediators and modulators. Exp Neurol 2005; 192: 444-462.
7. Drummond PD, Finch PM, Skipworth S, Blockey P: Pain increases during sympathetic arousal in patients with complex regional pain syndrome. Neurology 2001; 57: 1296-1303.
8. Kaufmann I, Eisner C, Richter P, Huge V, Beyer A, Chouker A, Schelling G, Thiel M: Psychoneuroendocrine stress response may impair neutrophil function in complex regional pain syndrome. Clin Immunol 2007; 125: 103-111.
9. Carrier EJ, Patel S, Hillard CJ: Endocannabinoids in neuroimmunology and stress. Curr Drug Targets CNS Neurol Disord 2005; 4: 657-665.
10. Grotenhermen F: Pharmacology of cannabinoids. Neuro Endocrinol Lett 2004; 25: 14-23.
11. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561-564.
12. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P: Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995; 232: 54-61.
13. Schatz AR, Lee M, Condie RB, Pulaski JT, Kaminski NE: Cannabinoid receptors CB 1 and CB 2 : a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 1997; 142: 278-287.
14. Van der Stelt M, Trevisani M, Vellani V, De Petrocellis L, Moriello AS, Campi C, Mc- Naughton P, Geppetti P, Di Marzo V: Anandamide acts as intracellular messenger amplifying Ca 2+ influx via TRPV1 channels. EMBO J 2005; 24: 3026-3037.
15. Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, Rubino T, Michalski CW, Marsicano G, Monory K, Mackie K, Marian C, Batkai S, Parolaro D, Fischer MJ, Reeh P, Kunos G, Kress M, Lutz B, Woolf CJ, Kuner R: Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci 2007; 10: 870-879.
16. Ibrahim MM, Rude ML, Stagg NJ, Mata HP, Lai J, Vanderah TW, Porreca F, Buckley NE, Makriyannis A, Malan TP: CB 2 cannabinoid receptor mediation of antinociception. Pain 2006; 122: 36-42.
17. Batkai S, Osei-Hyiaman D, Pan H, El Assal O, Rajesh M, Mukhopadhyay P, Hong F, Harvey-White J, Jafri A, Hasko G, Huffman JW, Gao B, Kunos G, Pacher P: Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. FASEB J 2007; 21: 1788-1800.
18. Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, Lutz B, Baker D, Dittel BN: Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB 1 on neurons and CB 2 on autoreactive T cells. Nat Med 2007; 13: 492-497.
19. Tasker J: Endogenous cannabinoids take the edge off neuroendocrine responses to stress. Endocrinology 2004; 145: 5429-5430.
20. Stanton-Hicks M, Jänig W, Hassenbusch S, Haddox JD, Boas R, Wilson P: Reflex sympathetic dystrophy - changing concepts and taxonomy. Pain 1995; 63: 127-133.
21. Bruehl S, Harden RN, Galer BS, Saltz S, Bertram M, Backonja M, Gayles R, Rudin N, Bhugra MK, Stanton-Hicks M: External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria. Pain 1999; 81: 147-154. (Pubitemid 29199910)
22. Gerbershagen U: Organisierte Schmerzbehandlung - Eine Standortbestimmung. Internist 1986; 27: 459-469.
23. Weisaeth L: Torture of a Norwegian ship's crew. The torture, stress reactions and psychiatric after-effects. Acta Psychiatr Scand Suppl 1989; 355: 63-72.
24. Vogeser M, Hauer D, Christina AS, Huber E, Storr M, Schelling G: Release of anandamide from blood cells. Clin Chem Lab Med 2006; 44: 488-491.
25. Grande LA, Loeser JD, Ozuna J, Ashleigh A, Samii A: Complex regional pain syndrome as a stress response. Pain 2004; 110: 495-498.
26. Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A: Exercise activates the endocannabinoid system. Neuroreport 2003; 14: 2209-2211.
27. Schelling G, Hauer D, Azad SC, Schmoelz M, Chouker A, Schmidt M, Hornuss C, Rippberger M, Briegel J, Vogeser M: Effect of general anesthesia on anandamide blood levels in humans. Anesthesiology 2006; 104: 273-277.
28. Kaufmann I, Schelling G, Eisner C, Richter HP, Krauseneck T, Vogeser M, Hauer D, Campolongo P, Chouker A, Beyer A, Thiel M: Anandamide and neutrophil function in patients with fibromyalgia. Psychoneuroendocrinology 2008; 33: 676-685.
29. Fowler CJ: The cannabinoid system and its pharmacological manipulation - a review, with emphasis upon the uptake and hydrolysis of anandamide. Fundam Clin Pharmacol 2006; 20: 549-562.
30. Azad SC, Monory K, Marsicano G, Cravatt BF, Lutz B, Zieglgänsberger W, Rammes G: Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. J Neurosci 2004; 24: 9953-9961.
31. Connell K, Bolton N, Olsen D, Piomelli D, Hohmann AG: Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia. Neurosci Lett 2006; 397: 180-184.
32. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B: The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002; 418: 530-534.
33. Roozendaal B, Quirarte GL, McGaugh JL: Stress-activated hormonal systems and the regulation of memory storage. Ann NY Acad Sci 1997; 821: 247-258.
34. Pertwee RG: Cannabinoid receptors and pain. Prog Neurobiol 2001; 63: 569-611.
35. Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker JM, Holmes PV, Crystal JD, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D: An endocannabinoid mechanism for stressinduced analgesia. Nature 2005; 435: 1108-1112.
36. Suplita RL, Farthing JN, Gutierrez T, Hohmann AG: Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla. Neuropharmacology 2005; 49: 1201-1209.
37. Ullrich O, Merker K, Timm J, Tauber S: Immune control by endocannabinoids - new mechanisms of neuroprotection? J Neuroimmunol 2007; 184: 127-135.
38. Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H: The cannabinoid system and immune modulation. J Leukoc Biol 2003; 74: 486-496.
39. Cabral GA, Marciano-Cabral F: Cannabinoid- mediated exacerbation of brain infection by opportunistic amebae. J Neuroimmunol 2004; 147: 127-130.
40. Kishimoto S, Muramatsu M, Gokoh M, Oka S, Waku K, Sugiura T: Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells. J Biochem (Tokyo) 2005; 137: 217-223.
41. Kraft B, Kress HG: Indirect CB 2 receptor and mediator-dependent stimulation of human whole-blood neutrophils by exogenous and endogenous cannabinoids. J Pharmacol Exp Ther 2005; 315: 641-647.
42. Ziring D, Wei B, Velazquez P, Schrage M, Buckley NE, Braun J: Formation of B and T cell subsets require the cannabinoid receptor CB 2 . Immunogenetics 2006; 58: 714-725.
43. D'Argenio G, Valenti M, Scaglione G, Cosenza V, Sorrentini I, Di Marzo V: Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. FASEB J 2006; 20: 568-570.
44. Izzo AA, Capasso F, Costagliola A, Bisogno T, Marsicano G, Ligresti A, Matias I, Capasso R, Pinto L, Borrelli F, Cecio A, Lutz B, Mascolo N, Di Marzo V: An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice. Gastroenterology 2003; 125: 765-774.
45. Di Marzo V, Izzo AA: Endocannabinoid overactivity and intestinal inflammation. Gut 2006; 55: 1373-1376.
46. Van de Voorde S, Saha B, Mahadevan A, Razdan RK, Pertwee RG, Martin BR, Fowler CJ: Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase. Biochem Biophys Res Commun 2005; 337: 104-109.
47. van der Stelt SM, van Kuik JA, Bari M, van Zadelhoff G, Leeflang BR, Veldink GA, Finazzi- Agro A, Vliegenthart JF, Maccarrone M: Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. J Med Chem 2002; 45: 3709-3720.
48. Vogeser M, Schelling G: Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples. Clin Chem Lab Med 2007; 45: 1023-1025.